SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
------------
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED
IN STATEMENTS FILED PURSUANT TO
RULES 13d-1(b) AND (c) AND AMENDMENTS
THERETO FILED PURSUANT TO 13d-2
(Amendment No. 1)*
VIROPHARMA INCORPORATED
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON
- --------------------------------------------------------------------------------
(Title of Class of Securities)
928241 10 8
- --------------------------------------------------------------------------------
(CUSIP Number)
--------------------------
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall
not be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 6 Pages
<PAGE>
CUSIP No. 928241 10 8 13G Page 2 of 6 Pages
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATIONS NOS. OF ABOVE PERSONS
Dennis J. Gorman
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
5 SOLE VOTING POWER
NUMBER OF 0
SHARES
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY EACH 0
REPORTING
PERSON WITH 7 SOLE DISPOSITIVE POWER
0
8 SHARED DISPOSITIVE POWER
0
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* |_|
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.0%
12 TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Item 1.
(a) Name of Issuer.
ViroPharma Incorporated, a Delaware corporation (the "Issuer").
(b) Address of Issuer's Principal Executive Offices.
The Issuer's principal executive offices are located at 76 Great
Valley Parkway, Malvern, Pennsylvania 19355.
Item 2.
(a) Names of Persons Filing.
This statement is filed by Dennis J. Gorman.
(b) Address of Principal Business Office.
The principal business office of each of Gorman is Two Galleria
Tower, 13455 Noel Road, Suite 1670, Dallas, Texas 75240.
(c) Citizenship.
Gorman is a U.S. citizen.
(d) Title of Class of Securities.
This statement relates to shares of Common Stock, par value $.002
per share (the "Common Stock"), of the Issuer.
(e) CUSIP Number.
928241 10 8
Item 3.
This statement is not being filed pursuant to Rule 13d-1(b) or
13d-2(b).
Page 3 of 6 Pages
<PAGE>
Item 4. Ownership.
(a) Amount Beneficially Owned.
(i) Gorman beneficially owns zero(0) shares of Common Stock.
(b) Percent of Class.
(i) Gorman -- 0.0%.
(c) Power to vote or direct the vote and dispose or direct the
disposition of securities. Gorman has neither sole nor shared
power to vote or dispose or to direct the vote or disposition
of any shares of Common Stock.
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check
the following [ X ]
Page 4 of 6 Pages
<PAGE>
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
Not applicable.
Page 5 of 6 Pages
<PAGE>
Signatures
After reasonable inquiry and to the best knowledge and belief of the
undersigned, the undersigned certifies1 that the information set forth in this
statement is true, complete and correct.
February 13, 1998 /s/ Dennis J. Gorman
---------------------------------------------
Dennis J. Gorman
Page 6 of 6 Pages
